Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development.

Human Vaccines & Immunotherapeutics
NorAziyah Mat RahimSazaly AbuBakar

Abstract

In 2017, the World Health Organization (WHO) named A. baumannii as one of the three antibiotic-resistant bacterial species on its list of global priority pathogens in dire need of novel and effective treatment. With only polymyxin and tigecycline antibiotics left as last-resort treatments, the need for novel alternative approaches to the control of this bacterium becomes imperative. Vaccines against numerous bacteria have had impressive records in reducing the burden of the respective diseases and addressing antimicrobial resistance; as in the case of Haemophilus influenzae type b . A similar approach could be appropriate for A. baumannii. Toward this end, several potentially protective antigens against A. baumannii were identified and evaluated as vaccine antigen candidates. A licensed vaccine for the bacteria, however, is still not in sight. Here we explore and discuss challenges in vaccine development against A. baumannii and the promising approaches for improving the vaccine development process.

References

Oct 26, 2000·Current Opinion in Microbiology·R Rappuoli
Jan 18, 2006·PLoS Genetics·Pierre-Edouard FournierJean-Michel Claverie
Nov 17, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H-W LeeJ Kim
Nov 30, 2007·Occupational Medicine·David Baxter
Mar 20, 2008·PloS One·David VallenetStéphane Cruveiller
Jun 11, 2008·Infection and Immunity·Thomas A RussoAnthony A Campagnari
Jul 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy J WhitmanRobert A Bonomo
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Jun 23, 2009·Trends in Immunology·Wilbur H ChenMarcelo B Sztein
Nov 11, 2009·Infection and Immunity·Ariana Peck, Elizabeth D Mellins
May 11, 2010·Cold Spring Harbor Perspectives in Biology·Thomas J SilhavySuzanne Walker
May 14, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D M SengstockK S Kaye
Sep 2, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Bruce Y LeeLee H Harrison
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Jennifer H MoffattJohn D Boyce
Oct 12, 2010·Journal of Global Infectious Diseases·Vikas ManchandaNp Singh
Oct 30, 2010·Immunity·Alessandro Sette, Rino Rappuoli
Apr 20, 2011·Microbes and Environments·Hamuel James DoughariSpinney Benade
Jun 18, 2011·Vaccine·Michael J McConnellJerónimo Pachón
Nov 23, 2011·Infection and Immunity·Leticia V BentancorTomás Maira-Litrán
Mar 6, 2012·The Journal of Antimicrobial Chemotherapy·Guanpingsheng LuoAshraf S Ibrahim
May 2, 2012·Virulence·Aoife HowardRoy D Sleator
May 10, 2012·FEMS Microbiology Reviews·Michael J McConnellJerónimo Pachón
Jul 25, 2012·Infection and Immunity·Leticia V BentancorTomás Maira-Litrán
Jan 23, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Abiola Olumuyiwa OlaitanJean Marc Rolain
Mar 5, 2013·Chembiochem : a European Journal of Chemical Biology·Anna ProschakHelge B Bode
Mar 20, 2013·Infection and Immunity·Kerstin HubertVincent Weynants
May 22, 2013·Antimicrobial Agents and Chemotherapy·Greg HarrisWangxue Chen
Jun 25, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Yoichi HirakiFumio Kawano
Jan 1, 2014·Frontiers in Cellular and Infection Microbiology·Brittany L Mortensen, Eric P Skaar
Jan 15, 2014·Infection and Immunity·Milene Tavares BatistaLuís C S Ferreira
Mar 8, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Eva MortensenDuc J Vugia
May 27, 2014·Frontiers in Microbiology·Germán L Rosano, Eduardo A Ceccarelli
Jul 22, 2014·Immunology·Tal GefenJacob Pitcovski
Aug 13, 2014·Antimicrobial Agents and Chemotherapy·Catlyn BlanchardPaul M Dunman

❮ Previous
Next ❯

Methods Mentioned

BETA
genetic modification
bronchoalveolar lavage

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.